Stay updated on AAV2/6 Gene Therapy SB-525 in Severe Hemophilia A Clinical Trial
Sign up to get notified when there's something new on the AAV2/6 Gene Therapy SB-525 in Severe Hemophilia A Clinical Trial page.

Latest updates to the AAV2/6 Gene Therapy SB-525 in Severe Hemophilia A Clinical Trial page
- Check7 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check14 days agoChange DetectedA sitewide NIH announcement says the agency is transitioning from using “Artificial Intelligence” to “Super Intelligence” terminology. The study page itself remains a 403 error page.SummaryDifference1%

- Check21 days agoChange DetectedThe footer now identifies the site as revision v3.7.2 instead of v3.7.1.SummaryDifference0.2%

- Check28 days agoChange DetectedThe footer’s site revision identifier changed from v3.7.0 to v3.7.1 while the page continued to show a 403 Forbidden error.SummaryDifference0.2%

- Check48 days agoChange DetectedThe page now displays a 403 Forbidden error with a minimal header, indicating the study record content is blocked and not accessible.SummaryDifference20%

- Check70 days agoChange DetectedThe page footer updated to Revision: v3.6.6, replacing the previous Revision: v3.6.5.SummaryDifference0.0%

Stay in the know with updates to AAV2/6 Gene Therapy SB-525 in Severe Hemophilia A Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AAV2/6 Gene Therapy SB-525 in Severe Hemophilia A Clinical Trial page.